Advertisement

Genetics and Genetic Counseling Related Issues

  • Martha A. NanceEmail author
Chapter
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

One would hope that there would be few emergencies related to genetic testing for movement disorders, but we have reviewed below several situations that qualify, including perception of urgency around testing, family conflicts and psychosocial complications related to testing, and problems related to misunderstanding of genetic facts. The physician can minimize the potential for genetic emergencies through proper education of, and support for, patients and their families. The judicious use of genetics specialists, such as genetic counselors, is an invaluable asset to the neurologist.

Keywords

Genetic Counseling Gene Test Essential Tremor Huntington Disease Predictive Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Paulsen JS, Hoth KF, Nehl C, Stierman L. Critical periods of suicide risk in Huntington’s disease. Am J Psychiatry. 2005;162:725–31.PubMedCrossRefGoogle Scholar
  2. 2.
    Foncke EM, Schuurman PR, Speelman JD. Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology. 2006;66:142–3.PubMedCrossRefGoogle Scholar
  3. 3.
    Misbahuddin A, Placzek M, Lennox G, Taanman JW, Warner TT. Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene. Mov Disord. 2007;22:1173–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson’s disease: a prospective study of 45 cases. J Neurol. 1991;238:281–7.PubMedGoogle Scholar
  5. 5.
    Nazem S, Siderowf AD, Duda JE, et al. Suicidal and death ideation in Parkinson’s disease. Mov Disord. 2008;23:1573–9.PubMedCrossRefGoogle Scholar
  6. 6.
    McMonagle P, Hutchinson M, Lawlor B. Hereditary spastic paraparesis and psychosis. Eur J Neurol. 2006;13:874–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Vahter L, Braschinsky M, Hladre S, Gross-Paju K. The prevalence of depression in hereditary spastic paraplegia. Clin Rehabil. 2009;23:857–61.PubMedCrossRefGoogle Scholar
  8. 8.
    Powell A, Chandrasekharan S, Cook-Deegan R. Spinocerebellar ataxia: patient and health professional perspectives on whether and how patents affect access to clinical genetic testing. Genet Med. 2010;12 suppl 4:S83–110.PubMedCrossRefGoogle Scholar
  9. 9.
    Anonymous. Guidelines for the molecular genetics predictive test in Huntington’s disease: International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea. Neurology. 1994;44:1533–36.Google Scholar
  10. 10.
    Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet. 1999;64:1293–304.PubMedCrossRefGoogle Scholar
  11. 11.
    Clifton JM, VanBeuge SS, Mladenka C, Wosnik KK. The Genetic Information Nondiscrimination Act 2008: what clinicians should understand. J Am Acad Nurse Pract. 2010;22:246–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Lilani A. Ethical issues and policy analysis for genetic testing: Huntington’s disease as a paradigm for diseases with a late onset. Hum Reprod Genet Ethics. 2005;11:28–34.PubMedGoogle Scholar
  13. 13.
    Borry P, Stultiens L, Nus H, Cassiman JJ, Direickx K. Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet. 2006;70:374–81.PubMedCrossRefGoogle Scholar
  14. 14.
    Borry P, Howard HC, Senecal K, Avard D. Health-related direct-to-consumer genetic testing: a review of companies’ policies with regard to genetic testing in minors. Fam Cancer. 2010;9:51–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Oster E, Dorsey ER, Bausch J, et al. Fear of health insurance loss among individuals at risk for Huntington disease. Am J Med Genet A. 2008;146A:2070–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Kitzman R. Views of discrimination among individuals confronting genetic disease. J Genet Couns. 2010;19:68–83.CrossRefGoogle Scholar
  17. 17.
    Bombard Y, Veenstra G, Friedman JM, et al. Perceptions of genetic discrimination among people at risk for Huntington’s disease: a cross-sectional survey. BMJ. 2009;338:b2175. doi: 10:1136/bmj.b2175.PubMedCrossRefGoogle Scholar
  18. 18.
    Hoth KF, Paulsen JS, Moser DJ, Tranel D, Clark LA, Bechara A. Patients with Huntington’s disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol. 2007;29:365–76.PubMedCrossRefGoogle Scholar
  19. 19.
    Browner CH, Preloran HM. Neurogenetic diagnoses. New York, NY: Routledge; 2010. p. 37–48.Google Scholar
  20. 20.
    Nance MA, Sevenich EA, Schut LJ. Knowledge of genetics and attitudes towards genetic testing in two hereditary ataxia (SCA1) kindreds. Am J Med Genet. 1994;54:242–8.PubMedCrossRefGoogle Scholar
  21. 21.
    GeneTests website. http://www.GeneTests.org (2010). Accessed 1 Aug 2010.

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Neurology, Struthers Parkinson’s CenterUniversity of MinnesotaGolden ValleyUSA

Personalised recommendations